BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26071763)

  • 21. Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas?
    Iacobone M; Schiavi F; Bottussi M; Taschin E; Bobisse S; Fassina A; Opocher G; Favia G
    Surgery; 2011 Dec; 150(6):1194-201. PubMed ID: 22136840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
    Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
    Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
    Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
    Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association.
    Hernandez KG; Ezzat S; Morel CF; Swallow C; Otremba M; Dickson BC; Asa SL; Mete O
    Virchows Arch; 2015 Jun; 466(6):727-32. PubMed ID: 25800244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medullary thyroid carcinomas with bilateral phaeochromocytomas.
    Slavotinek A; De la Lande IS; Head R
    Australas Ann Med; 1968 Nov; 17(4):320-6. PubMed ID: 5701923
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetics of pheochromocytoma and paraganglioma in Spanish patients.
    Cascón A; Pita G; Burnichon N; Landa I; López-Jiménez E; Montero-Conde C; Leskelä S; Leandro-García LJ; Letón R; Rodríguez-Antona C; Díaz JA; López-Vidriero E; González-Neira A; Velasco A; Matias-Guiu X; Gimenez-Roqueplo AP; Robledo M
    J Clin Endocrinol Metab; 2009 May; 94(5):1701-5. PubMed ID: 19258401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-generation panel sequencing identifies
    Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
    Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology and genetics of phaeochromocytoma and paraganglioma.
    Turchini J; Cheung VKY; Tischler AS; De Krijger RR; Gill AJ
    Histopathology; 2018 Jan; 72(1):97-105. PubMed ID: 29239044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
    Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
    Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
    Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
    Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.
    McInerney-Leo AM; Marshall MS; Gardiner B; Benn DE; McFarlane J; Robinson BG; Brown MA; Leo PJ; Clifton-Bligh RJ; Duncan EL
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):25-33. PubMed ID: 24102379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial bilateral pheochromocytoma with medullary carcinoma of the thyroid. The second kindred of familial pheochromocytoma in Japan.
    Sato T; Seino M; Kitahara O; Ono I; Miura Y
    Jpn Heart J; 1971 Jul; 12(4):405-13. PubMed ID: 5314718
    [No Abstract]   [Full Text] [Related]  

  • 34. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
    Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.
    Sbardella E; Cranston T; Isidori AM; Shine B; Pal A; Jafar-Mohammadi B; Sadler G; Mihai R; Grossman AB
    Endocrine; 2018 Jan; 59(1):175-182. PubMed ID: 28477304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.
    Jochmanova I; Abcede AMT; Guerrero RJS; Malong CLP; Wesley R; Huynh T; Gonzales MK; Wolf KI; Jha A; Knue M; Prodanov T; Nilubol N; Mercado-Asis LB; Stratakis CA; Pacak K
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1051-1063. PubMed ID: 32062700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations.
    Guerrero-Pérez F; Fajardo C; Torres Vela E; Giménez-Palop O; Lisbona Gil A; Martín T; González N; Díez JJ; Iglesias P; Robledo M; Villabona C
    Eur J Intern Med; 2019 Nov; 69():14-19. PubMed ID: 31431315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
    Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
    Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: multiple endocrine neoplasia type 3.
    Khairi MR; Dexter RN; Burzynski NJ; Johnston CC
    Medicine (Baltimore); 1975 Mar; 54(2):89-112. PubMed ID: 1117836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield.
    Horton C; LaDuca H; Deckman A; Durda K; Jackson M; Richardson ME; Tian Y; Yussuf A; Jasperson K; Else T
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1917-e1923. PubMed ID: 35026032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.